샘플 요청 목록

 카트 문의
시장보고서
상품코드
1659393

세계의 백신 전달 디바이스 시장

Vaccine Delivery Devices
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 93 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 백신 전달 디바이스 시장은 2030년까지 66억 달러에 도달

2024년에 51억 달러로 추정되는 세계의 백신 전달 디바이스 시장은 분석 기간인 2024-2030년에 CAGR 4.4%로 성장하며, 2030년에는 66억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 주사기는 CAGR 4.4%를 기록하며, 분석 기간 종료까지 53억 달러에 달할 것으로 예상됩니다. 제트 분사기 부문의 성장률은 분석 기간 중 CAGR 4.8%로 추정됩니다.

미국 시장은 14억 달러, 중국은 CAGR 7.5%로 성장 예측

미국의 백신 전달 디바이스 시장은 2024년에 14억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 14억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 7.5%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 1.2%와 5.0%로 예측됩니다. 유럽에서는 독일이 CAGR 2.1%로 성장할 것으로 예측됩니다.

세계 백신 전달 디바이스 시장 - 주요 동향 및 촉진요인 정리

백신 전달 디바이스란 무엇이며, 왜 현대 예방접종에 필수적인가?

백신 전달 디바이스는 백신을 안전하고, 효과적이고, 정확하게 투여하기 위해 고안된 특수한 툴나 기술을 말합니다. 주사기, 무침주사기, 마이크로니들 패치, 비강주사기, 피내주사기, 경구투여기 등이 포함됩니다. 불활화 백신, 약독화 백신, mRNA 백신, 아단위 백신, 바이러스 벡터 백신을 포함한 다양한 유형의 백신을 전달하는데 사용되며, 최적의 면역반응을 얻기 위해 백신이 적절한 조직에 도달하도록 합니다. 이러한 장비는 백신 투여의 효율성과 정확성을 향상시킬 뿐만 아니라 환자의 순응도를 높이고, 주사침 손상 위험을 줄이며, 낭비를 최소화합니다.

백신 전달 디바이스의 중요성은 안전하고 효과적인 백신 투여를 보장함으로써 예방접종 프로그램의 성공을 지원하는 능력에 있습니다. 효율적인 백신 투여는 높은 예방접종률을 달성하기 위해 필수적이며, 특히 집단 예방접종 캠페인이나 감염병을 통제하기 위한 공중보건 노력에 있어서는 더욱 그러합니다. 자동 비활성화 주사기와 같은 장비는 재사용을 방지하고 감염 위험을 줄이는 데 도움이 되며, 바늘을 사용하지 않는 주사기는 바늘 공포증을 가진 사람들의 백신 수용성을 향상시킵니다. 특히 전염병, 정기 예방접종, 신종 감염병 대응 등 전 세계에서 백신 접종에 대한 수요가 증가함에 따라 백신 전달 디바이스는 적시에 효과적인 예방접종 활동을 지원하는 의료 인프라의 필수 요소로 자리매김하고 있습니다.

기술의 발전은 백신 전달 디바이스 시장을 어떻게 형성하고 있는가?

기술의 발전으로 백신 전달 디바이스의 설계, 안전성 및 효율성이 크게 향상되어 전 세계 예방접종 프로그램의 혁신을 촉진하고 있습니다. 주요 개발 중 하나는 마이크로니들 패치의 도입으로, 통증 없이 피부 내로 백신을 투여할 수 있는 최소 침습적 방법을 제공합니다. 마이크로니들 패치는 백신으로 코팅되거나 채워져 있고 자가 투여가 가능하므로 집단 예방접종 캠페인이나 외딴 지역, 자원이 부족한 환경에 이상적입니다. 이 패치는 냉장 보관이 필요하지 않기 때문에 콜드체인 물류를 줄이고, 특히 개발도상국에서 백신에 대한 광범위한 접근을 용이하게 합니다.

또 다른 주요 발전은 바늘 없는 주사기 개발입니다. 이 주사기는 고압의 흐름을 이용하여 바늘을 사용하지 않고 피부를 통해 백신을 투여합니다. 이러한 장비는 바늘에 찔리는 부상의 위험을 줄이고, 환자의 순응도를 높이며, 생물학적 유해 폐기물을 최소화합니다. 무침 주사기는 독감, 홍역, 홍역, 간염 등의 백신 접종에 사용되고 있으며, COVID-19 및 결핵과 같은 새로운 백신에도 적용되고 있습니다. 주사바늘을 사용하지 않는 시스템과 더불어 자동 개폐식 주사기의 기술 혁신으로 예방접종시 안전성이 향상되었습니다. 이 주사기는 한 번 사용하면 자동으로 잠기도록 설계되어 재사용을 방지하고 교차 오염의 위험을 줄이기 위해 특히 집단 캠페인에서 안전한 백신 접종에 필수적인 요소입니다.

디지털 기술을 통합한 스마트 전달 장비의 등장은 시장에도 변화를 가져오고 있습니다. 스마트 주사기 및 웨어러블 주사기는 투약 정확도 모니터링, 투약 상황 추적, 접종률에 대한 실시간 데이터 수집이 가능하여 의료 서비스 프로바이더가 예방접종 프로그램 및 백신 추적을 개선하는 데 도움을 주고 있습니다. 또한 비강 투여 시스템의 발전으로 비침습적 백신 투여의 선택권이 확대되어 독감 백신과 같은 백신을 보다 간편하고 효율적으로 투여할 수 있게 되었습니다. 이러한 기술 혁신은 백신 전달 디바이스의 성능과 안전성을 향상시킬 뿐만 아니라, 보다 접근하기 쉽고, 사용하기 쉽고, 지속가능한 예방접종 솔루션이라는 세계 목표에도 부합합니다.

다양한 예방접종 프로그램에서 백신 전달 디바이스의 새로운 적용 사례는 무엇인가?

백신 전달 디바이스는 보다 효율적이고, 접근하기 쉽고, 안전한 예방접종 방법의 필요성으로 인해 다양한 예방접종 프로그램에 적용이 확대되고 있습니다. 정기적인 소아 예방접종 프로그램에서는 홍역, 디프테리아, 소아마비 등의 질병에 대한 백신을 투여하기 위해 자동주사기나 근육주사기와 같은 장비가 일반적으로 사용되고 있습니다. 이러한 장비는 정확한 투여와 안전한 투여를 보장하고, 높은 예방접종률을 달성하고, 백신으로 예방 가능한 질병을 예방하기 위한 전 세계의 노력을 돕고 있습니다. 독감, 폐렴구균, COVID-19 예방접종을 포함한 성인 예방접종 프로그램에서 바늘 없는 주사기와 마이크로니들 패치는 특히 주사바늘 공포증이 있는 환자들에게 더 빠른 투약, 통증 감소, 환자 순응도 향상 등의 이점을 제공함으로써 많은 지지를 받고 있습니다.

COVID-19 팬데믹과 신종 감염병에 대응하기 위한 신속하고 대규모 백신 접종 캠페인에는 다용도로 확장 가능한 전달 솔루션이 필요하며, COVID-19 팬데믹 기간 중 효율적인 백신 접종을 위해 근육내 백신용 자동 분리형 주사기부터 비강 스프레이에 이르기까지 다양한 전달 장비가 도입되었습니다. 비강 스프레이에 이르기까지 다양한 전달 장비가 도입되었습니다. 안정성과 효능을 유지하기 위해 특수한 전달 기술을 필요로 하는 mRNA 백신의 개발도 특수 주사기 및 콜드체인 대응 장비의 채택을 촉진했습니다. 광견병이나 결핵과 같은 백신의 피내 주사기 사용이 확대되면서 자원이 제한된 환경에서 백신 공급을 극대화하기 위해 투여량을 절약하는 전략을 가능하게 하는 장비에 대한 수요가 증가하고 있습니다.

암 백신과 HIV 및 간염과 같은 만성질환 치료용 백신도 표적화할 수 있는 혁신적인 전달장비의 혜택을 받고 있습니다. 예를 들어 치료용 백신을 일정 기간 중 피하로 투여하는 웨어러블 주사기는 암 면역 요법에서 유망한 솔루션으로 떠오르고 있습니다. 백신 전달 디바이스의 다양성과 적응성은 다양한 예방접종 프로그램에서 효과적인 백신 접종률 달성, 환자 결과 개선, 세계 보건 구상 지원 등 중요한 역할을 담당하고 있습니다.

백신 전달 디바이스 시장의 성장 원동력은 무엇인가?

백신 전달 디바이스 시장의 성장은 전 세계 예방접종 활동 증가, 백신 개발의 발전, 보다 안전하고 효율적인 전달 방법의 필요성 등 여러 가지 요인에 의해 이루어지고 있습니다. 주요 성장 요인 중 하나는 정기적인 예방접종 프로그램, 대유행 대비, 신종 감염병에 대한 대응으로 인한 백신 수요 증가입니다. 각국 정부와 국제기구가 백신 접종률과 접종률 향상에 집중하면서 신뢰할 수 있고 확장 가능한 전달 장비에 대한 수요가 급증하고 있습니다. 마이크로니들 패치, 자동 비활성화 주사기, 바늘 없는 주사기 등의 기술 혁신은 기존 주사바늘 사용 방식과 관련된 물류 문제를 완화하여 집단 예방접종 캠페인에 도움을 주고 있습니다.

COVID-19 백신의 급속한 개발 및 배포로 인해 보다 신속한 투여와 안전하고 효과적인 예방접종을 가능하게 하는 첨단 전달 장비의 필요성이 부각되고 있습니다. 특수한 전달 기술을 필요로 하는 mRNA, DNA, 바이러스 벡터 백신이 확대됨에 따라 백신의 안정성을 유지하고 면역 반응을 최적화하는 혁신적인 장비에 대한 수요가 더욱 증가하고 있습니다. 환자의 순응도를 높이고, 주사바늘과 관련된 위험을 줄이고, 바늘을 사용하지 않는 최소침습적 전달 방법에 대한 관심이 높아지면서 선진국과 개발도상국 모두에서 새로운 전달 기술의 채택이 가속화되고 있습니다.

정부 구상, 의료 개혁, 백신 접근성 프로그램 확대도 시장 성장에 기여하고 있습니다. 예를 들어 세계보건기구(WHO)와 유니세프(UNICEF)는 안전한 주사 방법의 사용을 강조하고 교차 오염을 방지하고 백신의 안전성을 향상시키기 위해 자동 비활성화 주사기 및 기타 안전 설계 장비의 채택을 장려하고 있습니다. 또한 재택의료 및 분산형 의료의 부상으로 마이크로니들 패치, 비강주사제 등 자가투여형 백신 디바이스에 대한 수요가 증가하여 보다 유연한 백신 접종 전략을 지원하고 있습니다. 디바이스 기술, 디지털 통합, 지속가능한 제조 분야의 지속적인 혁신으로 백신 전달 디바이스 시장은 백신의 접근성, 안전성, 효율성을 높이기 위한 전 세계적인 노력에 힘입어 강력한 성장세를 보일 것으로 예상됩니다.

부문

디바이스(주사기, 제트 인젝터, 기타 디바이스) ; 투여경로(근육접종, 피하접종, 피내접종, 경피접종, 기타 투여경로)

조사 대상 기업의 예(주목 합계 42사)

  • 3M
  • Becton Dickinson & Company
  • BioJect Medical Technologies, Inc.(Inovio Pharmaceuticals, Inc.)
  • Corium International, Inc
  • Gerresheimer AG
  • Pharmajet, Inc
  • Schott AG
  • Valeritas
  • Vaxxas

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장의 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.03.07

Global Vaccine Delivery Devices Market to Reach US$6.6 Billion by 2030

The global market for Vaccine Delivery Devices estimated at US$5.1 Billion in the year 2024, is expected to reach US$6.6 Billion by 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Syringes, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$5.3 Billion by the end of the analysis period. Growth in the Jet Injectors segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 7.5% CAGR

The Vaccine Delivery Devices market in the U.S. is estimated at US$1.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 7.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.2% and 5.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Vaccine Delivery Devices Market - Key Trends & Drivers Summarized

What Are Vaccine Delivery Devices, and Why Are They So Crucial in Modern Immunization?

Vaccine Delivery Devices are specialized tools and technologies designed to administer vaccines safely, effectively, and accurately. These devices include syringes, needle-free injectors, microneedle patches, nasal sprays, intradermal injectors, and oral delivery devices. They are used to deliver various types of vaccines, including inactivated, live-attenuated, mRNA, subunit, and viral vector vaccines, ensuring the vaccines reach the appropriate tissue for optimal immune response. These devices not only improve the efficiency and accuracy of vaccine administration but also enhance patient compliance, reduce the risk of needle-stick injuries, and minimize wastage.

The importance of vaccine delivery devices lies in their ability to support successful immunization programs by ensuring safe and effective vaccine administration. Efficient vaccine delivery is critical for achieving high immunization coverage, especially in mass vaccination campaigns and public health initiatives aimed at controlling infectious diseases. Devices like auto-disable syringes help prevent reuse and reduce infection risks, while needle-free injectors improve vaccine acceptance among needle-phobic populations. As global vaccination needs grow, particularly in response to pandemics, routine immunization, and emerging infectious diseases, vaccine delivery devices have become essential components of healthcare infrastructure, supporting timely and effective immunization efforts.

How Are Technological Advancements Shaping the Vaccine Delivery Devices Market?

Technological advancements have significantly improved the design, safety, and efficiency of Vaccine Delivery Devices, driving innovation across immunization programs worldwide. One of the major developments is the introduction of microneedle patches, which offer a painless, minimally invasive way to deliver vaccines intradermally. Microneedle patches are coated or filled with vaccines and can be self-administered, making them ideal for mass vaccination campaigns, remote locations, and low-resource settings. These patches do not require refrigeration, reducing cold chain logistics and facilitating broader access to vaccines, especially in developing countries.

Another key advancement is in the development of needle-free injectors, which use high-pressure streams to deliver vaccines through the skin without the use of needles. These devices reduce the risk of needle-stick injuries, improve patient compliance, and minimize biohazard waste. Needle-free injectors have been used in administering vaccines for diseases like influenza, measles, and hepatitis, and are being adapted for emerging vaccines, including those for COVID-19 and tuberculosis. In addition to needle-free systems, innovations in auto-disable syringes have improved safety during immunization. These syringes are designed to lock automatically after a single use, preventing reuse and reducing the risk of cross-contamination, making them crucial for safe vaccine administration, especially in mass campaigns.

The rise of smart delivery devices that integrate digital technology is transforming the market as well. Smart syringes and wearable injectors can monitor dosing accuracy, track administration, and collect real-time data on vaccination coverage, helping healthcare providers improve immunization programs and vaccine tracking. Advances in intranasal delivery systems have also expanded the options for non-invasive vaccine administration, offering easy and efficient delivery of vaccines such as the flu vaccine. These technological innovations are not only improving the performance and safety of vaccine delivery devices but also aligning with global goals for more accessible, user-friendly, and sustainable immunization solutions.

What Are the Emerging Applications of Vaccine Delivery Devices Across Different Immunization Programs?

Vaccine Delivery Devices are finding expanding applications across a wide range of immunization programs, driven by the need for more efficient, accessible, and safer vaccination methods. In routine childhood immunization programs, devices like auto-disable syringes and intramuscular injectors are commonly used to deliver vaccines for diseases such as measles, diphtheria, and polio. These devices ensure precise dosing and safe administration, supporting global efforts to achieve high immunization coverage and prevent vaccine-preventable diseases. In adult immunization programs, including influenza, pneumococcal, and COVID-19 vaccinations, needle-free injectors and microneedle patches are gaining traction as they offer faster administration, reduced pain, and improved patient compliance, particularly among needle-phobic individuals.

In response to pandemics and emerging infectious diseases, rapid and large-scale vaccination campaigns require versatile and scalable delivery solutions. During the COVID-19 pandemic, a variety of delivery devices were deployed to ensure efficient vaccine rollout, from auto-disable syringes for intramuscular vaccines to intranasal sprays for easier administration. The development of mRNA vaccines, which require specific delivery techniques to maintain stability and efficacy, has also driven the adoption of specialized injectors and cold-chain-compatible devices. The expanding use of intradermal injectors for vaccines like rabies and tuberculosis highlights the growing demand for devices that allow for dose-sparing strategies, maximizing vaccine supply in resource-limited settings.

Therapeutic vaccines, such as cancer vaccines and those for chronic diseases like HIV and hepatitis, also benefit from innovative delivery devices that provide targeted administration. For example, wearable injectors that deliver therapeutic vaccines subcutaneously over a controlled period have emerged as a promising solution in cancer immunotherapy. The versatility and adaptability of vaccine delivery devices across these diverse immunization programs reflect their critical role in achieving effective vaccination coverage, improving patient outcomes, and supporting global health initiatives.

What Drives Growth in the Vaccine Delivery Devices Market?

The growth in the Vaccine Delivery Devices market is driven by several factors, including increasing global immunization efforts, advancements in vaccine development, and the need for safer and more efficient delivery methods. One of the primary growth drivers is the rising demand for vaccines, fueled by routine immunization programs, pandemic preparedness, and efforts to address emerging infectious diseases. As governments and international organizations focus on improving vaccination rates and coverage, the demand for reliable, scalable delivery devices has surged. Innovations such as microneedle patches, auto-disable syringes, and needle-free injectors have supported mass vaccination campaigns, reducing the logistical challenges associated with traditional needle-based methods.

The rapid development and deployment of COVID-19 vaccines highlighted the critical need for advanced delivery devices that can facilitate faster administration and ensure safe, effective immunization. The expansion of mRNA, DNA, and viral vector vaccines, which often require specialized delivery techniques, has further driven demand for innovative devices that maintain vaccine stability and optimize immune response. The increasing focus on needle-free and minimally invasive delivery methods, which improve patient compliance and reduce needle-associated risks, has accelerated the adoption of new delivery technologies in both developed and developing regions.

Government initiatives, healthcare reforms, and expanded vaccine access programs have also contributed to market growth. For example, the World Health Organization (WHO) and UNICEF have emphasized the use of safe injection practices, promoting the adoption of auto-disable syringes and other safety-engineered devices to prevent cross-contamination and improve vaccine safety. Additionally, the rise of home-based and decentralized healthcare services has increased demand for self-administrable vaccine devices, such as microneedle patches and nasal sprays, supporting more flexible vaccination strategies. With ongoing innovations in device technology, digital integration, and sustainable manufacturing, the Vaccine Delivery Devices market is poised for robust growth, driven by global efforts to enhance vaccine accessibility, safety, and efficiency.

SCOPE OF STUDY:

The report analyzes the Vaccine Delivery Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Device (Syringes, Jet Injectors, Other Devices); Route of Administration (Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination, Other Route of Administrations)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • 3M
  • Becton Dickinson & Company
  • BioJect Medical Technologies, Inc. (Inovio Pharmaceuticals, Inc.)
  • Corium International, Inc
  • Gerresheimer AG
  • Pharmajet, Inc
  • Schott AG
  • Valeritas
  • Vaxxas

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Vaccine Delivery Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Vaccine Administration Drives Demand for Vaccine Delivery Devices
    • Advancements in Needle-Free Injection Systems Propel Vaccine Delivery Device Market
    • Expanding Role of Self-Administered Vaccines Sets the Stage for Device Adoption
    • Case Overview: Demand for Single-Use Syringes Enhances Vaccine Delivery Device Market
    • Innovations in Microneedle Technology Generate New Opportunities for Vaccine Devices
    • Focus on Reducing Vaccine Wastage Bodes Well for Delivery Device Adoption
    • Growing Use of Auto-Disable Syringes Sustains Vaccine Delivery Device Market
    • Expanding Role of Prefilled Syringes Enhances Vaccine Delivery Market Growth
    • Push for Improved Immunization Programs Drives Vaccine Delivery Device Adoption
    • Case Overview: Innovations in Smart Syringes Propel Vaccine Delivery Devices
    • Innovations in Intradermal Delivery Propel Vaccine Delivery Device Growth
    • Focus on Mass Immunization Programs Bodes Well for Vaccine Delivery Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Vaccine Delivery Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Vaccine Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Vaccine Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Syringes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Jet Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Jet Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Jet Injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Intramuscular Vaccination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Intramuscular Vaccination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Intramuscular Vaccination by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Subcutaneous Vaccination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Subcutaneous Vaccination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Subcutaneous Vaccination by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Intradermal Vaccination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Intradermal Vaccination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Intradermal Vaccination by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Route of Administrations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Route of Administrations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Route of Administrations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • JAPAN
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • CHINA
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • EUROPE
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Vaccine Delivery Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Vaccine Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • FRANCE
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • GERMANY
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Vaccine Delivery Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Vaccine Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • INDIA
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Vaccine Delivery Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Vaccine Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Vaccine Delivery Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Vaccine Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030
  • AFRICA
    • Vaccine Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Vaccine Delivery Devices by Device - Syringes, Jet Injectors and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Vaccine Delivery Devices by Device - Percentage Breakdown of Value Sales for Syringes, Jet Injectors and Other Devices for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Vaccine Delivery Devices by Route Of Administration - Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Vaccine Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Intramuscular Vaccination, Subcutaneous Vaccination, Intradermal Vaccination and Other Route of Administrations for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제